Avenue Therapeutics, Inc.

ATXIOTCHealthcare● Active

$0.31

$-0.04(-12.06%)

Market Cap$1021440

P/E Ratio—

52W High$0.9699

52W Low$0.15

Avg Volume5K

Open$0.31

Beta-0.17

Employees Ownership Insider Trades

Avenue Therapeutics, Inc. (ATXI) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · ATXI · as of Mar 30, 2026

Latest filing snapshot

+0+0.00%vs prior year

Avenue Therapeutics, Inc. (ATXI) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

Change (1Y)

Growth % (1Y)

+0.00%

Revenue / Employee

$702.0K

Net Income / Employee

$-1.45M

Market Cap

$1M

ATXI Employee Count

2017 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-03-30	2025-12-31	2	+0	+0.00%
2025-03-31	2024-12-31	2	-1	-33.33%
2024-03-18	2023-12-31	3	+1	+50.00%
2023-03-31	2022-12-31	2	-2	-50.00%
2022-03-25	2021-12-31	4	+0	+0.00%
2021-03-31	2020-12-31	4	+0	+0.00%
2020-03-30	2019-12-31	4	-2	-33.33%
2019-03-12	2018-12-31	6	+4	+200.00%
2018-03-01	2017-12-31	2	—	—

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

CARM

Carisma Therapeutics, Inc.

Dermata Therapeutics, Inc.

8$1M #4

ARTL

Artelo Biosciences, Inc.

6$3M #5

ATXI

Avenue Therapeutics, Inc.YOU

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · ATXI peer comparison

About ATXI employees

ATXI Employees · Headcount

Avenue Therapeutics, Inc. (ATXI) employee data is sourced from the annual SEC 10-K filing. As of 2025, Avenue Therapeutics, Inc. had 2 full-time employees globally. Full-time employees only. Global consolidated headcount.

Avenue Therapeutics, Inc. employs 2 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $702,000, reflecting the company's operational efficiency.

Avenue Therapeutics, Inc.'s workforce increased by 0 (0.00%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Avenue Therapeutics, Inc.'s revenue per employee of $702,000 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

ATXI Employees · 5 questions

As of the latest SEC 10-K filing (2025), Avenue Therapeutics, Inc. had 2 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Avenue Therapeutics, Inc. employee counthow many employees does Avenue Therapeutics, Inc. haveATXI total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-30